Argus Research analyst David Toung maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 14. The company’s shares ...

Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...

At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...

On the first day of spring training for the 2025 Red Sox, Rafael Devers made one thing clear: He does not want to cede third ...

The president's early actions are rubbing some of his swing voters the wrong way.

The Boston Celtics lost Oshae Brissett and Svi Mykhailiuk during the summer, and Brad Stevens was unable to find a ...

The Boston Red Sox got their guy. On Wednesday night the team agreed to sign All-Star third baseman Alex Bregman to a ...

Can Boston break out of a postseason slump? Here are the Red Sox playoffs and World Series odds for the 2025 MLB season.

Alex Bregman's long foray into free agency is over after he agreed to a three-year deal with the Boston Red Sox worth $120 ...

In addition, technological advancements such as the increasing use of AI, predictive analysis, and advanced algorithms are ...

A proposed law would require delivery companies to acquire insurance, permits, and submit monthly reports to the city.